Nano Dimension Ltd.(NNDM), a 3D printed electronics has announced that its wholly-owned subsidiary, Nano Dimension Technologies Ltd., has supplied, in return for payment, its flagship DragonFly 2020 3D Printer to Syqe Medical Ltd. Syqe is the Tel Aviv-based developer of the world’s first selective-dose, pharmaceutical grade medical cannabis inhaler. It uses 3D printers to prototype and produce inhalers, which have been used in Israel’s Rambam Hospital for more than a year. Syqe Medical plans to use Nano Dimension’s technology to further develop its inhalers.
Nano Dimension’s beta program involves the delivery of the company’s DragonFly 2020 3D Printers to leading companies and partners worldwide through a leasing model. These customers are pioneering additive manufacturing technology and techniques for electronics and circuitry, and are active in a variety of industries.